# Abbott and Google Collaborate on AI-Enhanced Glucose Monitoring

> Abbott and Google are set to transform diabetes care by integrating AI-driven glucose monitoring with personal health insights, enhancing user experience through the Google Health app.

**Source**: google.com | **Published**: 2026-08-12 | **Type**: article

## Key Facts

- Abbott's Lingo CGM aims to enhance user engagement through AI, driving market differentiation.
- Partnership with Google leverages AI for personalized health insights, enhancing competitive edge.
- One of the largest metabolic health studies could redefine industry standards for diabetes management.
- Integration with Google Health app may boost Abbott's market share in the growing diabetes tech sector.
- AI-driven insights could lead to improved customer retention, impacting long-term financial performance.

## Summary

Abbott Laboratories has entered a strategic partnership with Google to enhance glucose monitoring through artificial intelligence. Announced today, this multiyear collaboration aims to integrate Abbott’s Lingo biowearable technology with Google Health’s platform, providing users with a comprehensive view of their metabolic health. This initiative is significant as it not only leverages advanced AI capabilities but also positions both companies at the forefront of the rapidly evolving diabetes management market.

Abbott, based in Abbott Park, Illinois, launched its Lingo continuous glucose monitor (CGM) in September 2024, marking a pivotal moment in diabetes care. The Lingo device, which is available over-the-counter, builds on Abbott’s established FreeStyle Libre technology, known for its effectiveness in glucose monitoring. The partnership with Google, a subsidiary of Alphabet, is designed to create an intuitive, AI-driven user experience that integrates glucose data with other health metrics. This integration will be available through the Google Health app, which also collects data from other health devices, such as Fitbit.

The collaboration will focus on three primary areas: integrating real-time glucose insights from the Lingo device into Google Health, enhancing the Google Health Coach with personalized recommendations based on glucose data, and conducting a significant real-world metabolic health study. This study aims to correlate continuous glucose monitoring with lifestyle factors such as activity, sleep, and overall well-being, generating insights that could inform future health recommendations.

Olivier Ropars, divisional VP of Abbott’s Lingo business, emphasized the partnership's potential to shift the focus from disease treatment to proactive health management. By combining Abbott's expertise in biowearables with Google's AI capabilities, the companies aim to deliver personalized health insights at an unprecedented scale. This approach not only addresses immediate health needs but also supports long-term behavioral changes that can prevent chronic health issues.

The implications of this partnership extend beyond individual health management. As diabetes prevalence continues to rise globally, the demand for innovative solutions in diabetes care is increasing. This collaboration positions Abbott and Google to capture significant market share in the diabetes technology sector, which is projected to grow substantially in the coming years. Competitors in the space, including Dexcom and Medtronic, will need to respond to this enhanced offering, potentially accelerating their own innovation efforts.

Moreover, the integration of AI into health monitoring represents a broader trend in the healthcare industry, where technology is increasingly used to personalize patient care. By harnessing AI to provide actionable insights, Abbott and Google are not only improving user engagement but also setting a new standard for how health data can be utilized. This could lead to a paradigm shift in how metabolic health is understood and managed, influencing future product development and partnerships within the healthcare ecosystem.

Looking ahead, the success of this collaboration may catalyze further advancements in AI-driven health solutions, encouraging other tech companies to explore similar partnerships. As consumer expectations for personalized health management continue to rise, the ability to provide real-time, actionable insights will become a critical differentiator in the health tech market. This partnership between Abbott and Google signals a transformative approach to diabetes management, with potential implications that could reshape the future of healthcare technology.

## Entities

- **Companies**: Abbott, Google, Alphabet
- **Products**: Lingo, FreeStyle Libre
- **Technologies**: AI, continuous glucose monitor, Google Health
- **People**: Olivier Ropars

## Key Concepts

glucose insights, AI-powered experience, metabolic health, personalized recommendations, health and wellness metrics, real-world metabolic health studies, biowearables, healthier habits

## Definitions

- **Lingo**: Lingo is an over-the-counter continuous glucose monitor (CGM) biosensor launched by Abbott for monitoring diabetes.
- **AI**: Artificial Intelligence (AI) refers to the simulation of human intelligence processes by machines, particularly computer systems.
- **Google Health Coach**: Google Health Coach is an AI-enabled feature that provides personalized, contextual recommendations to help users improve their health habits.
- **metabolic health**: Metabolic health refers to the state of the body's metabolic processes, including how well it manages glucose and other substances.
- **biowearables**: Biowearables are devices that monitor biological data, often used for health tracking and management.

## Use Cases

- Integrating glucose insights into Google Health
- Providing tailored recommendations through Google Health Coach
- Conducting large-scale metabolic health studies
- Monitoring diabetes with Lingo
- Tracking health metrics alongside glucose trends
- Generating insights into the relationship between glucose and everyday behaviors

## Frequently Asked Questions

**What is the purpose of the Abbott and Google partnership?**

The partnership aims to leverage AI to provide users with comprehensive glucose insights and personalized health recommendations through the Google Health app.

**How does the Lingo device work?**

Lingo is a continuous glucose monitor that tracks glucose levels and provides users with insights into their metabolic health, helping them make informed lifestyle choices.

**What kind of recommendations can users expect from Google Health Coach?**

Users can expect personalized recommendations related to nutrition, activity, sleep, and recovery, designed to help them build healthier habits.

**What is the significance of the real-world metabolic health study?**

This study aims to integrate various data sources to uncover connections between lifestyle factors and metabolic health, ultimately informing more personalized health guidance.

**When was the Lingo device launched?**

The Lingo device was launched in the U.S. in September 2024 as an over-the-counter continuous glucose monitor.

## Links

- [Read on Welcome.AI](https://welcome.ai/content/abbott-and-google-collaborate-on-ai-enhanced-glucose-monitoring)
- [Original source](https://www.google.com/url?rct=j&sa=t&url=https://www.drugdeliverybusiness.com/abbott-google-to-deliver-blood-glucose-insights-through-artificial-intelligence/&ct=ga&cd=CAIyGjBhYTY2NTYyNmEwMjY5ZjU6Y29tOmVuOlVT&usg=AOvVaw3G3_a0oFpTn_ejsPMq1hHa)
- [Abbott Laboratories](https://welcome.ai/company/abbott-laboratories): Featured company

---

Source: Welcome.AI | https://welcome.ai/content/abbott-and-google-collaborate-on-ai-enhanced-glucose-monitoring